Novel treatment of stifle lameness in a horse

The horse’s stifle is often considered particularly complex because of the large number of associated intraarticular and periarticular soft tissue structures [1]. Furthermore, injuries to the soft tissues oftentimes occur…

Sound gets the spring back in his step thanks to Arthramid Vet

Have you ever heard of Sound? Sound is an 8-year-old brown thoroughbred racehorse born in Germany in 2013. After several successful seasons of racing in Germany, with 7 wins from…

Japan Racing Association (JRA)

Japan Racing Association (JRA) institute Laboratory for Racing Chemistry testing confirms Arthramid® Vet is free of Prohibited Substances in Japan Racing. To provide assurances to veterinarians in Japan, a representative…

Joint disease in horses – How to treat navicular disease.

Navicular disease (ND) is a chronic degenerative condition of the navicular bone of the foot and is one of the most common and frustrating causes of horse lameness. The syndrome…

New hydrogel technology to treat joint lameness in horses

New hydrogel technology, researched and adapted for veterinary use, offers a pioneering treatment for osteoarthritis in horses without an active pharmaceutical. Osteoarthritis (OA) is often cited as the most significant…

Treatment of tenosynovitis of the deep digital flexor tendon sheath in a racing TB

In this second issue we report on how an experienced racetrack veterinarian managed a case of chronic tenosynovitis of the deep digital flexor tendon sheath in a racing Thoroughbred. Case…

Treatment of subchondral bone disease in the equine fetlock joint

We recently met with experienced racetrack veterinarians’ that have introduced Arthramid Vet into their management of subchondral bone disease in racing Thoroughbreds’. Introduction: Subchondral bone is composed of a subchondral…

Pioneering treatment for arthritis may improve equine welfare and reduce wastage

Equine veterinarians have a range of options to treat lameness in horses caused by osteoarthritis (OA) and practitioners use all means at their disposal to ensure horses are exposed to the absolute…

Arthrosamid 2.5% PAAG – The Human Equivalent

Arthrosamid is the 2.5% polyacrylamide hydrogel developed as a long-acting intra-articular injection for the treatment of osteoarthritis in humans. Arthrosamid® is a new type of treatment for knee osteoarthritis that…

Use of Arthramid Vet in Canine Intra-articular injections

Nupsala Learning Resources in the UK recently published a webinar on Canine Intra-articular Injection. Dr Karen Cook BA VetMB BSc (Hons) MRCVS presents an informative webinar on the injection technique…

2.5% PAAG for managing intercarpal joint lameness – AAEP Presentation 2019

New treatments for osteoarthritis are always welcomed, and many times a cutting-edge product is presented at AAEP to advise practitioners of the possibilities to manage the equine athlete. It is…

UK Equine Case Series 341 Horses and 804 joints

A case series report following the treatment with 2.5% polyacrylamide hydrogel of 804 joints in 341 horses (average of 2.36 joints per horse). The treatments were carried out by three…

Interested in talking to us and learning more?

Schedule a time with one of our experts
BOOK NOW